These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 12799856)

  • 21. Regulation of calcitonin gene-related peptide secretion from trigeminal nerve cells by botulinum toxin type A: implications for migraine therapy.
    Durham PL; Cady R; Cady R
    Headache; 2004 Jan; 44(1):35-42; discussion 42-3. PubMed ID: 14979881
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neurogenic model of migraine.
    Buzzi MG; Bonamini M; Moskowitz MA
    Cephalalgia; 1995; 15(4):277-80. PubMed ID: 7585923
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activation of extracellular signal-regulated kinase in the trigeminal ganglion following both treatment of the dura mater with capsaicin and cortical spreading depression.
    Iwashita T; Shimizu T; Shibata M; Toriumi H; Ebine T; Funakubo M; Suzuki N
    Neurosci Res; 2013; 77(1-2):110-9. PubMed ID: 23962823
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Pathophysiology of migraine: models to explain the generation of migraine headache].
    Ebersberger A
    Anaesthesist; 2002 Aug; 51(8):661-7. PubMed ID: 12391526
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cortical spreading depression does not result in the release of calcitonin gene-related peptide into the external jugular vein of the cat: relevance to human migraine.
    Piper RD; Edvinsson L; Ekman R; Lambert GA
    Cephalalgia; 1993 Jun; 13(3):180-3; discussion 149. PubMed ID: 8395344
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of phosphorylated extracellular signal-regulated kinase, calcitonin gene-related peptide and cyclooxygenase-2 in experimental rat models of migraine.
    Dong X; Hu Y; Jing L; Chen J
    Mol Med Rep; 2015 Aug; 12(2):1803-9. PubMed ID: 25892078
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Current views on the pathogenesis of migraine aura].
    Domitrz I
    Neurol Neurochir Pol; 2007; 41(1):70-5. PubMed ID: 17330183
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Functional immunohistochemistry of neuropeptides and nitric oxide synthase in the nerve fibers of the supratentorial dura mater in an experimental migraine model.
    Knyihár-Csillik E; Tajti J; Chadaide Z; Csillik B; Vécsei L
    Microsc Res Tech; 2001 May; 53(3):193-211. PubMed ID: 11301495
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Experimental animal models of migraine.
    Buzzi MG
    Neurol Sci; 2022 Sep; 43(9):5779-5781. PubMed ID: 35900621
    [TBL] [Abstract][Full Text] [Related]  

  • 30. One hundred years of migraine research: major clinical and scientific observations from 1910 to 2010.
    Tfelt-Hansen PC; Koehler PJ
    Headache; 2011 May; 51(5):752-78. PubMed ID: 21521208
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacological synergy: the next frontier on therapeutic advancement for migraine.
    Blumenfeld A; Gennings C; Cady R
    Headache; 2012 Apr; 52(4):636-47. PubMed ID: 22221151
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genes, proteases, cortical spreading depression and migraine: impact on pathophysiology and treatment.
    Moskowitz MA
    Funct Neurol; 2007; 22(3):133-6. PubMed ID: 17925161
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cortical spreading depression and central pain networks in trigeminal nuclei modulation: time for an integrated migraine pathogenesis perspective.
    De Simone R; Ranieri A; Montella S; Bonavita V
    Neurol Sci; 2013 May; 34 Suppl 1():S51-5. PubMed ID: 23695046
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intrinsic brain activity triggers trigeminal meningeal afferents in a migraine model.
    Bolay H; Reuter U; Dunn AK; Huang Z; Boas DA; Moskowitz MA
    Nat Med; 2002 Feb; 8(2):136-42. PubMed ID: 11821897
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neurogenic inflammation in primary headaches.
    Fusco M; D'Andrea G; Miccichè F; Stecca A; Bernardini D; Cananzi AL
    Neurol Sci; 2003 May; 24 Suppl 2():S61-4. PubMed ID: 12811594
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Cortical spreading depression and pain: a missing link in the pathophysiology of migraine?].
    Kowa H; Takigawa H; Nakashima K
    Rinsho Shinkeigaku; 2014; 54(12):1006-8. PubMed ID: 25672694
    [TBL] [Abstract][Full Text] [Related]  

  • 37. From spreading depression to the trigeminovascular system.
    Dalkara T; Zervas NT; Moskowitz MA
    Neurol Sci; 2006 May; 27 Suppl 2():S86-90. PubMed ID: 16688636
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Gap junctional intercellular communication: a new mechanism in pathophysiology of migraine with aura. Therapeutic applications].
    Sarrouilhe D; Dejean C
    Pathol Biol (Paris); 2012 Dec; 60(6):392-8. PubMed ID: 22633071
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Topiramate inhibits trigeminovascular activation: an intravital microscopy study.
    Akerman S; Goadsby PJ
    Br J Pharmacol; 2005 Sep; 146(1):7-14. PubMed ID: 15980877
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuropeptides in migraine and cluster headache.
    Edvinsson L; Goadsby PJ
    Cephalalgia; 1994 Oct; 14(5):320-7. PubMed ID: 7828188
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.